Changed "Your role" to "My Role"

This commit is contained in:
2026-02-19 14:00:20 +00:00
parent 012c905c90
commit a1f7088b48
39 changed files with 46 additions and 21804 deletions
+2 -2
View File
@@ -96,9 +96,9 @@ export function KPIDetail({ kpi }: KPIDetailProps) {
<p style={paragraphStyle}>{context}</p>
</div>
{/* Your role paragraph */}
{/* My role paragraph */}
<div>
<h3 style={sectionHeadingStyle}>Your Role</h3>
<h3 style={sectionHeadingStyle}>My Role</h3>
<p style={paragraphStyle}>{role}</p>
</div>
+44 -43
View File
@@ -35,12 +35,34 @@ export const investigations: Investigation[] = [
'14,000 patients identified for cost-effective alternatives',
'£2.6M annual savings potential identified',
'£2M on target for delivery this financial year',
'Novel GP payment system linking rewards to savings',
'Reimplemented in DAX for sharing as internal Power BI tool',
'Novel GP payment system linking rewards to savings'
],
techStack: ['Python', 'Pandas', 'SQL'],
skills: ['Health Economics', 'Medicines Optimisation', 'Prescribing Analytics'],
techStack: ['DAX', 'Python', 'SQL'],
skills: ['Health Economics', 'Medicines Optimisation', 'Power BI'],
thumbnail: '/thumbnails/switchingdashboard.jpg',
},
{
id: 'inv-nms-training',
name: 'NMS National Training Video',
requestedYear: 2018,
reportedYear: 2018,
status: 'Live',
resultSummary: 'Shared nationally across Tesco Pharmacy',
requestingClinician: 'A. Charlwood',
methodology: 'Self-produced training video covering the full New Medicine Service workflow — the three-stage consultation process (Engagement, Intervention, Follow-up), eligibility criteria for target conditions (asthma/COPD, hypertension, anticoagulation, type 2 diabetes), and practical techniques like the "star" prescription marking system. Features a patient case study demonstrating how NMS intervention corrected inhaler technique, and presents adherence data showing non-adherence halving from 20% to 10%. Created independently to address inconsistent NMS delivery across stores.',
results: [
'Shared across Tesco Pharmacy nationally to support delivery of the New Medicine Service',
'Empowered non-pharmacist staff to identify and enrol eligible patients',
'Improved consistency and quality of NMS engagement from non-pharmacist staff',
'Supported successful uplift in NMS performance metrics across stores',
],
techStack: ['Video Production'],
skills: ['Training & Development', 'Clinical Services', 'Leadership'],
externalUrl: 'https://www.youtube.com/watch?v=Rm1wcX92XlQ',
thumbnail: '/thumbnails/nms.jpg',
},
{
id: 'inv-blueteq-gen',
name: 'Blueteq Generator',
@@ -60,46 +82,6 @@ export const investigations: Investigation[] = [
skills: ['High-Cost Drugs', 'Prior Approval', 'Process Automation'],
thumbnail: '/thumbnails/blueteq.jpg',
},
{
id: 'inv-cd-monitoring',
name: 'CD Monitoring System',
requestedYear: 2024,
reportedYear: 2024,
status: 'Complete',
resultSummary: 'Population-scale OME tracking',
requestingClinician: 'A. Charlwood',
methodology: 'Python-based controlled drug monitoring system calculating oral morphine equivalents (OME) across all opioid prescriptions to track patient-level exposure over time.',
results: [
'Patient-level OME tracking over time',
'High-risk patient identification',
'Potential diversion detection',
'Previously impossible population-scale analysis',
],
techStack: ['Python', 'SQL'],
skills: ['Controlled Drugs', 'Patient Safety', 'Prescribing Analytics'],
thumbnail: '/thumbnails/ome.jpg',
},
{
id: 'inv-nms-training',
name: 'NMS National Training Video',
requestedYear: 2018,
reportedYear: 2018,
status: 'Complete',
resultSummary: 'Shared nationally across Tesco Pharmacy',
requestingClinician: 'A. Charlwood',
methodology: 'Self-produced training video covering the full New Medicine Service workflow — the three-stage consultation process (Engagement, Intervention, Follow-up), eligibility criteria for target conditions (asthma/COPD, hypertension, anticoagulation, type 2 diabetes), and practical techniques like the "star" prescription marking system. Features a patient case study demonstrating how NMS intervention corrected inhaler technique, and presents adherence data showing non-adherence halving from 20% to 10%. Created independently to address inconsistent NMS delivery across stores.',
results: [
'Shared across Tesco Pharmacy nationally to support delivery of the New Medicine Service',
'Empowered non-pharmacist staff to identify and enrol eligible patients',
'Improved consistency and quality of NMS engagement from non-pharmacist staff',
'Supported successful uplift in NMS performance metrics across stores',
],
techStack: ['Video Production'],
skills: ['Training & Development', 'Clinical Services', 'Leadership'],
externalUrl: 'https://www.youtube.com/watch?v=Rm1wcX92XlQ',
thumbnail: '/thumbnails/nms.jpg',
},
{
id: 'inv-pathway-analysis',
name: 'Patient Pathway Analysis Platform',
@@ -121,4 +103,23 @@ export const investigations: Investigation[] = [
demoUrl: 'https://demo.charlwood.xyz',
thumbnail: '/thumbnails/pathways.jpg',
},
{
id: 'inv-cd-monitoring',
name: 'CD Monitoring System',
requestedYear: 2024,
reportedYear: 2024,
status: 'Complete',
resultSummary: 'Population-scale OME tracking',
requestingClinician: 'A. Charlwood',
methodology: 'Python-based controlled drug monitoring system calculating oral morphine equivalents (OME) across all opioid prescriptions to track patient-level exposure over time.',
results: [
'Patient-level OME tracking over time',
'High-risk patient identification',
'Potential diversion detection',
'Previously impossible population-scale analysis',
],
techStack: ['Python', 'SQL'],
skills: ['Controlled Drugs', 'Patient Safety', 'Prescribing Analytics'],
thumbnail: '/thumbnails/ome.jpg',
},
]